146 related articles for article (PubMed ID: 8833866)
1. Purification and gene cloning of a superantigen (YPM) produced by a patient strain of Yersinia pseudotuberculosis.
Takeda T; Yoshino K; Itoh Y; Abe J; Shimonishi Y; Kohsaka T
Contrib Microbiol Immunol; 1995; 13():331-3. PubMed ID: 8833866
[No Abstract] [Full Text] [Related]
2. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein.
Ito Y; Abe J; Yoshino K; Takeda T; Kohsaka T
J Immunol; 1995 Jun; 154(11):5896-906. PubMed ID: 7751634
[TBL] [Abstract][Full Text] [Related]
3. DNA sequencing of the gene encoding a bacterial superantigen, Yersinia pseudotuberculosis-derived mitogen (YPM), and characterization of the gene product, cloned YPM.
Miyoshi-Akiyama T; Abe A; Kato H; Kawahara K; Narimatsu H; Uchiyama T
J Immunol; 1995 May; 154(10):5228-34. PubMed ID: 7730627
[TBL] [Abstract][Full Text] [Related]
4. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains.
Yoshino K; Ramamurthy T; Nair GB; Fukushima H; Ohtomo Y; Takeda N; Kaneko S; Takeda T
J Clin Microbiol; 1995 Dec; 33(12):3356-8. PubMed ID: 8586739
[TBL] [Abstract][Full Text] [Related]
5. Clinical role for a superantigen in Yersinia pseudotuberculosis infection.
Abe J; Onimaru M; Matsumoto S; Noma S; Baba K; Ito Y; Kohsaka T; Takeda T
J Clin Invest; 1997 Apr; 99(8):1823-30. PubMed ID: 9109426
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of a novel superantigen produced by a clinical isolate of Yersinia pseudotuberculosis.
Yoshino K; Abe J; Murata H; Takao T; Kohsaka T; Shimonishi Y; Takeda T
FEBS Lett; 1994 Dec; 356(1):141-4. PubMed ID: 7988709
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a superantigen produced by Yersinia pseudotuberculosis.
Abe J; Takeda T
Prep Biochem Biotechnol; 1997; 27(2-3):173-208. PubMed ID: 9292925
[No Abstract] [Full Text] [Related]
8. Analysis of the superantigen-producing ability of Yersinia pseudotuberculosis strains of various serotypes isolated from patients with systemic or gastroenteric infections, wildlife animals and natural environments.
Ueshiba H; Kato H; Miyoshi-Akiyama T; Tsubokura M; Nagano T; Kaneko S; Uchiyama T
Zentralbl Bakteriol; 1998 Oct; 288(2):277-91. PubMed ID: 9809408
[TBL] [Abstract][Full Text] [Related]
9. Critical role of T cell migration in bacterial superantigen-mediated shock in mice.
Kano H; Ito Y; Matsuoka K; Nakajima T; Iwata T; Kohsaka T; Saito H; Abe J
Clin Immunol; 2004 Feb; 110(2):159-71. PubMed ID: 15003813
[TBL] [Abstract][Full Text] [Related]
10. The superantigen gene ypm is located in an unstable chromosomal locus of Yersinia pseudotuberculosis.
Carnoy C; Floquet S; Marceau M; Sebbane F; Haentjens-Herwegh S; Devalckenaere A; Simonet M
J Bacteriol; 2002 Aug; 184(16):4489-99. PubMed ID: 12142419
[TBL] [Abstract][Full Text] [Related]
11. A novel superantigenic exotoxin from Yersinia psuedotuberculosis and its position in the classification of the entire bacterial toxins.
Uchiyama T
Contrib Microbiol Immunol; 1995; 13():191-4. PubMed ID: 8833831
[No Abstract] [Full Text] [Related]
12. Purification, characterization and cloning of a novel variant of the superantigen Yersinia pseudotuberculosis-derived mitogen.
Ramamurthy T; Yoshino K; Abe J; Ikeda N; Takeda T
FEBS Lett; 1997 Aug; 413(1):174-6. PubMed ID: 9287138
[TBL] [Abstract][Full Text] [Related]
13. Identification of the functional region on the superantigen Yersinia pseudotuberculosis-derived mitogen responsible for induction of lymphocyte proliferation by using synthetic peptides.
Yoshino K; Takao T; Ishibashi M; Samejima Y; Shimonishi Y; Takeda T
FEBS Lett; 1996 Jul; 390(2):196-8. PubMed ID: 8706858
[TBL] [Abstract][Full Text] [Related]
14. [Virulence of Yersinia pseudotuberculosis strains isolated from environment as a threat to human epidemic].
Czyzewska I; Furowicz AJ
Przegl Epidemiol; 2003; 57(2):263-70. PubMed ID: 12910593
[TBL] [Abstract][Full Text] [Related]
15. Mutant OmpF porins of Yersinia pseudotuberculosis with deletions of external loops: structure-functional and immunochemical properties.
Sidorova OV; Khomenko VA; Portnyagina OY; Likhatskaya GN; Vakorina TI; Kim NY; Chistyulin DK; Solov'eva TF; Novikova OD
Biochem Biophys Res Commun; 2014 Mar; 445(2):428-32. PubMed ID: 24530904
[TBL] [Abstract][Full Text] [Related]
16. Evidence for superantigen production by Yersinia pseudotuberculosis.
Abe J; Takeda T; Watanabe Y; Nakao H; Kobayashi N; Leung DY; Kohsaka T
J Immunol; 1993 Oct; 151(8):4183-8. PubMed ID: 8409395
[TBL] [Abstract][Full Text] [Related]
17. Protection against Yersinia pseudotuberculosis infection conferred by a Lactococcus lactis mucosal delivery vector secreting LcrV.
Daniel C; Sebbane F; Poiret S; Goudercourt D; Dewulf J; Mullet C; Simonet M; Pot B
Vaccine; 2009 Feb; 27(8):1141-4. PubMed ID: 19135495
[TBL] [Abstract][Full Text] [Related]
18. Role of T cells and gamma interferon in Yersinia pseudotuberculosis-derived mitogen (YPM)-induced toxicity in mice.
Kano H; Ito Y; Matsuoka K; Iwata T; Saito H; Kohsaka T; Abe J
Adv Exp Med Biol; 2003; 529():137-9. PubMed ID: 12756745
[No Abstract] [Full Text] [Related]
19. Generated single point-mutations can considerably dismantle the lymphocyte overstimulation induced by Yersinia pseudotuberculosis superantigen.
Seprényi G; Ito Y; Kohsaka T
Cell Immunol; 1999 Mar; 192(2):96-106. PubMed ID: 10087177
[TBL] [Abstract][Full Text] [Related]
20. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms.
Uchiyama T; Miyoshi-Akiyama T; Kato H; Fujimaki W; Imanishi K; Yan XJ
J Immunol; 1993 Oct; 151(8):4407-13. PubMed ID: 8409410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
